Literature DB >> 6183970

N-acetyl procainamide causing torsades de pointes.

B Olshansky, J Martins, S Hunt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6183970     DOI: 10.1016/0002-9149(82)90489-1

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  9 in total

Review 1.  Drug-induced long QT syndrome.

Authors:  Prince Kannankeril; Dan M Roden; Dawood Darbar
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

Review 2.  QT interval abnormalities: risk factors and perioperative management in long QT syndromes and Torsades de Pointes.

Authors:  Alan David Kaye; Jacqueline Volpi-Abadie; J Michael Bensler; Adam M Kaye; James H Diaz
Journal:  J Anesth       Date:  2013-02-15       Impact factor: 2.078

Review 3.  Proarrhythmia, a serious complication of antiarrhythmic drugs.

Authors:  P J Podrid
Journal:  Curr Cardiol Rep       Date:  1999-11       Impact factor: 2.931

Review 4.  Acecainide (N-acetylprocainamide). A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cardiac arrhythmias.

Authors:  D W Harron; R N Brogden
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

Review 5.  Drug interactions with cisapride: clinical implications.

Authors:  E L Michalets; C R Williams
Journal:  Clin Pharmacokinet       Date:  2000-07       Impact factor: 6.447

6.  Long QT syndrome caused by N-acetyl procainamide in a patient on hemodialysis.

Authors:  Kenki Ashida; Takanao Mine; Takeshi Kodani; Hideyuki Kishima; Tohru Masuyama
Journal:  J Cardiol Cases       Date:  2015-03-16

Review 7.  Drug-induced QT interval prolongation: mechanisms and clinical management.

Authors:  Senthil Nachimuthu; Manish D Assar; Jeffrey M Schussler
Journal:  Ther Adv Drug Saf       Date:  2012-10

Review 8.  Torsades de pointes: prevention and therapy.

Authors:  A Keren; D Tzivoni
Journal:  Cardiovasc Drugs Ther       Date:  1991-04       Impact factor: 3.727

Review 9.  QT-interval prolonging drugs: mechanisms and clinical relevance of their arrhythmogenic hazards.

Authors:  M Zehender; S Hohnloser; H Just
Journal:  Cardiovasc Drugs Ther       Date:  1991-04       Impact factor: 3.727

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.